Search results
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 4 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 4 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 4 days agoStocks recently featured in the blog include: Novavax, Inc. NVAX, Sanofi SNY, Fulcrum Therapeutics,...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 6 days agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
WSAU Wausau· 4 days ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and...
NBC Securities Inc. Raises Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoNBC Securities Inc. grew its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 20.2% during the 4th quarter, according to the company in its most recent 13F filing ...
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 5 days agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
The Highest Paid CEOs of 2023
The Wall Street Journal· 5 hours agoPoor performance can slash the value of CEO equity awards. Covid-vaccine maker Moderna reported total pay of $17.1 million for CEO Stéphane Bancel last...
Moderna scores European victory over Pfizer and BioNTech in mRNA patent battle
Endpoints News· 4 days agoThe European Patent Office on Thursday handed a win to Moderna in a long-running patent battle with...
